Adequate pain management at end of life is certainly a united team effort By Sarah Guy.

Related StoriesBRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical SchoolUsing integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya DasAddressing standard of living needs in prostate malignancy: an interview with Professor Louis Denis Nurses have to place individual advocacy above fears of recrimination from physicians, they contend, after their results demonstrated that authoritative boundaries often prevent nurses from having the ability to convince doctors of the need to alter pain medicine regimens.The delivery of the first custom array designed for a 100,000-sample genotyping project to end up being performed using the Axiom Genotyping Remedy. The array, optimized for European populations, was developed in conjunction with experts from the Kaiser Permanente Division of University and Research of California, San Francisco as part of an NIH-funded task to make a new source for studying disease, health, and maturing. Signature programs to start two microarray-structured in vitro diagnostic products by the fourth one fourth of the year to enable earlier diagnosis and improved prognosis for CRC.